Global Clinical Laboratory Tests Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 206,645.00 Billion |
 Market Size (Forecast Year) |
USD 399,819.07 Billion |
 CAGR |
% |
| Major Markets Players |
全球临床实验室测试市场，按测试类型、临床（完整综合测试或全身测试）、完整身体计数、基本代谢面板 (BMP)、HGB/HCT）、测试、HbA1c 测试、BUN 肌酐测试、电解质测试、肾脏面板测试、脂质面板测试、常规、专业）、应用（寄生虫学、血液学、病毒学、毒理学、免疫学/血清学、组织病理学和尿液分析、最终用户（医院实验室、诊所实验室、中央/独立实验室、医生办公室实验室和其他 - 零售诊所）– 行业趋势和预测到 2029 年。
临床实验室测试市场分析和规模
根据世界卫生组织的数据，每年有超过 1700 万人死于由各种不健康行为、高血压和高胆固醇引起的心血管疾病。肝硬化、肝炎、肝癌、骨病、胆管阻塞和自身免疫性疾病都属于肝病组。肝炎在 2019 年占比最高，而由于生活方式紊乱和烟草和酒精消费的增加，预计肝硬化将成为预测期内增长最快的组别。
Data Bridge Market Research 分析，临床实验室测试市场在 2021 年为 2066.45 亿美元，预计到 2029 年将达到 3998.1907 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 8.6%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
临床实验室测试市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
测试类型、临床（全面测试或全身测试）、CBC（全身计数）、基本代谢组 (BMP)、HGB/HCT）、测试、HbA1c 测试、BUN 肌酐测试、电解质测试、肾脏组测试、脂质组测试、常规、专业）、应用（寄生虫学、血液学、病毒学、毒理学、免疫学/血清学、组织病理学和尿液分析、最终用户（医院实验室、诊所实验室、中央/独立实验室、医生办公室实验室和其他 - 零售诊所） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South AUmerica. |
|
Market Players Covered |
Abbott (U.S.), ARUP Laboratories (U.S.), OPKO Health, Inc. (U.S.), ioscientia Healthcare GmbH (Germany), Charles River Laboratories (U.S.), NeoGenomics Laboratories (U.S.), Genoptix, Inc. (U.S.), Healthscope (Australia), The Laboratory Glassware Co. (U.S.), Laboratory Corporation of America® Holdings (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), QIAGEN (Germany), Quest Diagnostics Incorporated (U.S.), Siemens Healthcare Private Limited (Germany), Tulip Diagnostics (P) Ltd. (India), Sonic Healthcare Limited (Australia), Merck KGaA (Germany) |
|
Market Opportunities |
|
Market Definition
Clinical laboratory test results are used in diagnostic decision making as part of clinical medicine. Clinical laboratory tests are classified into three types. The US Food and Drug Administration (FDA) determines the testing categories of tests that have been cleared for clinical use using a scoring system that considers the complexity of the testing, the stability of calibrators, controls, pre-analytical steps required, and the need for result interpretation. The test samples are analysed by a technician or your doctor to see if your results are within the normal range. Clinical laboratories are medical services that offer a wide range of research techniques to help doctors with diagnosis, therapeutic interventions, and patient supervision. These labs are run by medical technologists (clinical laboratory physicists), who are qualified to conduct experiments on collections of biological samples obtained from their patients. The vast majority of clinical labs are housed within or near medical facilities, making them accessible to both doctors and patients. Clinical laboratory classifications show that these facilities can include high-quality laboratory experiments required to meet clinical and public health demands.
Global Clinical Laboratory Tests Market Dynamics
Drivers
- Growing geriatric population will bolster the growth rate
The growing geriatric population is expected to drive the overall clinical laboratory test market. According to the World Population Prospects: the 2019 Revision data, approximately one in every eleven people in the world were over the age of 65 in 2019, and by 2050, it is estimated that approximately one in every six people will be over the age of 65. Clinical laboratory tests are being used more and more to diagnose age-related diseases.
Furthermore, the rising rate of insufficient exercise, unhealthy food consumption, and the resulting rise in cases of obesity are expected to increase the prevalence of various chronic diseases. The growing awareness of the importance of regular body profiling among healthcare professionals and patients around the world is drive up demand for clinical laboratory tests.
- Rising prevalence of target diseases
The market is expected to benefit from the rising prevalence of target diseases such as cardiovascular disease and diabetes during the forecast period. Cardiovascular diseases are the leading cause of death worldwide. Demand for point-of-care lipid testing is expected to be driven by unmet medical needs related to cardiovascular diseases and increased patient awareness. The World Health Organization predicts that cardiovascular diseases will be the leading cause of death and morbidity in 2021. In the last three decades, 17.7 million people have died from cardiovascular diseases, accounting for 31% of all fatalities worldwide.
The rising prevalence of lifestyle-related diseases such as obesity, the global smoking trend, and an unhealthy diet are among the factors contributing to the global rise in the incidence of renal and lipid-related disorders. Furthermore, as the global prevalence of diabetes rises, so does the number of patients who require clinical laboratory tests.
Opportunities
- Innovative solutions in clinical laboratory tests
Innovative solutions for improving efficiency and eliminating errors are expected to be a major rendering driver in this industry. Integrated workflow management systems, database management tools, and patient test records are becoming increasingly important in the healthcare industry, with organisations processing 100 to 150 billion samples per year. The implementation and development of data management and informatics solutions to support smooth operations are expected to drive market growth.
Restraints/Challenges
- Stringent governmental guidelines will restrict the growth rate
The stringent governmental guidelines and regulations on laboratory research are the main factors limiting the market growth. The maintenance of quality of clinical laboratory products is governed by country specific regulatory bodies. These bodies ensure protection from risks caused by flaws in design, technology, packaging, and manufacturing of the equipment or peripherals.
- Ambiguous regulatory framework
The healthcare industry relies heavily on regulatory frameworks established by organisations such as the FDA and EMA in the United States. There are no specific regulatory requirements for the diagnostic business in emerging markets such as China and India. Laboratory-designed tests (LDTs) are tests developed in-house clinical laboratories that provide accurate and timely results. LDT risks could reduce profit margins and cause delays in the marketing of newly designed tests. This factor is impeding the global clinical laboratory tests market's growth.
This clinical laboratory tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the clinical laboratory tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent developments
- In April 2022, Quest Diagnostics, based in Secaucus, New Jersey, has announced a number of organisational changes and senior leadership appointments to better support the company's two-point business strategy of accelerating growth and driving operational excellence.
- In April 2022, Abbott has updated its digital health app with its chronic pain neurostimulation devices, making it easier for clinicians to monitor how well patients respond to treatment. While using Abbott's Proclaim device range for spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy, the Neurosphere myPath app measures and reports patient-perceived pain relief and general well-being.
Global Clinical Laboratory Tests Market Scope
The clinical laboratory tests market is segmented on the basis of test type, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Clinical
- Complete Comprehensive Test or Complete Body Test
- Complete Body Count (CBC)
- Basic Metabolic Panel (BMP)
- HGB/HCT
- HbA1c Tests
- BUN Creatinine Tests
- Electrolytes Tests
- Renal Panel Tests
- Lipid Panel Tests
- Hepatitis
- Bile Duct Obstruction
- Liver Cirrhosis
- Liver Cancer
- Bone Disease
- Autoimmune Disorders
- Others
- Routine
- Speciality
Application
- Parasitology
- Haematology
- Virology
- Toxicology
- Immunology/Serology
- Histopathology
- Urinalysis
End Users
- Hospital Based Laboratories
- Clinics Based Laboratories
- Central/Independent Laboratories
- Physician Office-Based Laboratories
- Retail Clinic
- Other
临床实验室测试市场区域分析/见解
对临床实验室测试市场进行了分析，并按国家、测试类型、应用和最终用户提供了市场规模见解和趋势。
临床实验室测试市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于北美地区药品种类繁多，生物技术公司众多，北美在临床实验室检测市场占据主导地位。此外，技术进步不断加快也是该地区市场发展的驱动力，而老年人口也在增加，这增加了对诊断技术的需求。
由于研发部门的不断发展以及对医疗保健领域的投资不断增加，预计亚太地区将在 2022 年至 2029 年的预测期内实现最高增长率。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
临床实验室测试市场还为您提供每个国家/地区资本设备医疗保健支出增长、临床实验室测试市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对临床实验室测试市场的影响的详细市场分析。数据涵盖 2010-2020 年的历史时期。
竞争格局和临床实验室测试市场份额分析
临床实验室测试市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对临床实验室测试市场的关注有关。
临床实验室测试市场的一些主要参与者包括：
- 雅培（美国）
- ARUP 实验室（美国）
- OPKO Health, Inc.（美国）
- Bioscientia Healthcare GmbH（德国）
- Charles River Laboratories（美国）
- NeoGenomics 实验室（美国）
- Genoptix, Inc.（美国）
- Healthscope（澳大利亚）
- 实验室玻璃器皿公司（美国）
- 美国实验室控股公司（美国）
- 费森尤斯医疗保健股份公司（德国）
- QIAGEN（德国）
- Quest Diagnostics Incorporated（美国）
- 西门子医疗私人有限公司（德国）
- Tulip Diagnostics (P) Ltd.（印度）
- Sonic Healthcare Limited（澳大利亚）
- 默克集团（德国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
